phenylpiperazine has been researched along with Adenoma, Prostatic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alcántara-Hernández, R; Castello Branco, LA; Feijó, PR; García-Sáinz, JA; Nascimento-Viana, JB; Nasciutti, LE; Noël, F; Oliveira-Barros, E; Silva, CLM; Soares Romeiro, LA | 1 |
| Kumar, R; Singh, P | 1 |
2 other study(ies) available for phenylpiperazine and Adenoma, Prostatic
| Article | Year |
|---|---|
The α1-adrenoceptor-mediated human hyperplastic prostate cells proliferation is impaired by EGF receptor inhibition.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Cell Line; Cell Proliferation; ErbB Receptors; Humans; Hyperplasia; Male; Piperazines; Primary Cell Culture; Prostate; Prostatic Hyperplasia; Protein Kinase Inhibitors; Receptors, Adrenergic, alpha-1; Signal Transduction; Stromal Cells | 2019 |
Quantitative structure-activity relationship study of novel alpha1a-selective adrenoceptor antagonists.
Topics: Adrenergic Agonists; Adrenergic alpha-1 Receptor Antagonists; Binding Sites; Humans; Male; Piperazines; Piperidines; Prostatic Hyperplasia; Pyrimidinones; Quantitative Structure-Activity Relationship | 2001 |